Vitae Pharmaceuticals' Series C Round

Vitae Pharmaceuticals raised a round of funding on July 20, 2005.

Vitae Pharmaceuticals is a clinical stage biopharmaceutical company discovering and developing a portfolio of small molecule compounds that address disease areas, including: chronic kidney disease, di…

Articles about Vitae Pharmaceuticals' Series C Round: